March 2021

Preparing for Alternative Payment Models: Aligning Clinical Practice With Quality Metrics

03/16/2021

American Association of Community Cancer Centers

Quality reporting is a critical part of value-based care, providing the justification for optimal reimbursement and continued participation in alternative payment models. However, the gap between current clinical...

...

03/16/2021

Journal of Clinical Pathways

Medicine and Health Technology Are Advancing Exponentially—Greater Collaboration Will Be Key for Future Success

03/16/2021

Machine learning, artificial intelligence, immunotherapy, genomics, robotic limbs, wearable health-monitoring tech, mRNA vaccines—it is an exciting time in medical research and technology. Yet, we must be mindful...

...

03/16/2021

Journal of Clinical Pathways

Health Care Delivery Needs an Attitude Adjustment

03/16/2021

Lili Brillstein, MPH

New reimbursement models, along with the rise of accountable care, episodes of care/bundled payments, and vertical integration require the need for increased collaboration between payers and providers. While the...

New...

03/16/2021

Journal of Clinical Pathways

Clinical Pathways at Roswell Park Comprehensive Cancer Center: Understanding Off-Pathway Decisions

03/15/2021

Mishellene McKinney, MHA, RN, OCN—Column Editor

Founded in 2016, the Clinical Pathways Forum is a community of pathways professionals—now totaling 15 institutions from across the United States—who are utilizing clinical pathways in their practices and institutions...

...

03/15/2021

Journal of Clinical Pathways

Research Report

Electronic Consultations for Subspecialists: A Potential Virtual Pathway for Patient Clinic Visits

03/15/2021

Joshua D Hickman, MHA

Megan M Colgan, BA

Michelle M L’Heureux, MD, FACP

Christopher H Lowrey, MD

Kenneth R Meehan, MD

Abstract: With the onset of the COVID pandemic, computer-assisted clinic visits and telemedicine have become a critical aspect of patient care. As a rural National Cancer Institute-designated cancer center, the...

...

03/15/2021

Journal of Clinical Pathways

CAR T-Cell Therapy: Current Practice and Future Solutions to Optimize Patient Access

03/15/2021

Praveen Ramakrishnan Geethakumari, MD

Binod Dhakal, MD

Dheepthi Perumal Ramasamy, BS

Ankit J Kansagra, MD

Praveen Ramakrishnan Geethakumari, MD, and colleagues address clinical and financial challenges and provide solutions to optimize CAR-T cell therapy’s framework toward expanding access.

Praveen Ramakrishnan...

03/15/2021

Journal of Clinical Pathways

Department

Research in Review

03/16/2021

JCP Editors

Predictive Model for at Home Care Among Patients With Solid-Tumor Malignancies Researchers developed a predictive model for identifying admissions of patients with cancer who were potentially suitable for in-patient...

...

03/16/2021

Journal of Clinical Pathways

News

Conference Coverage

The 2021 American Society of Clinical Oncology Genitourinary Cancers Symposium

03/16/2021

JCP Editors

Apalutamide Plus ADT Improves OS in Metastatic Castration-Sensitive Prostate Cancer Among patients with metastatic castration-sensitive prostate cancer, apalutamide plus ADT improves OS with a significant reduction...

...

03/16/2021

Journal of Clinical Pathways

Column

COA Viewpoint

How Community Oncology Can Optimize COVID-19 Vaccine Administration

03/16/2021

Frederick M Schnell, MD, FACP

Recently, the Community Oncology Alliance Board of Directors submitted a letter to all 50 US governors to urge that local, independent oncology practices be given priority approval to administer COVID-19 vaccinations...

...

03/16/2021

Journal of Clinical Pathways

Feature

Research Report

Electronic Consultations for Subspecialists: A Potential Virtual Pathway for Patient Clinic Visits

03/15/2021

Joshua D Hickman, MHA

Megan M Colgan, BA

Michelle M L’Heureux, MD, FACP

Christopher H Lowrey, MD

Kenneth R Meehan, MD

...

03/15/2021

Journal of Clinical Pathways

Current Issue

April 2024

Volume 10

Issue 2

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

Biliary Tract Cancers (BTCs) Unveiled: Expert Perspectives on Unique Challenges and Management Considerations

11/20/2023

In this supplement, learn about the complexities of biliary tract cancer (BTC) with insights from a distinguished expert panel. The supplement examines the patient journey to diagnosis and treatment of BTCs, evaluates the impact of the...

In this supplement, learn about...

11/20/2023

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Twitter

Editorial Correspondence

March 2021

Department

News

Column

Feature

Current Issue

Special Reports

Subscribe

Twitter

Volume 7

Specialties

Events

Year Round Education

HMP Global Products